News

2016

WHA69 Intervention on Global Medicine Shortages and the Safety and Accessibility of Children’s Medication

HAI and KEI Submit WHA69 Intervention on Follow-up CEWG Report

HAI Co-signs Letter to Obama Administration Regarding Alleged U.S. Interference in Colombian Health Measure

HAI Submits Intervention on Establishing a Global Development and Stewardship Framework for Antimicrobial Medicines and Other Interventions at WHA69

Snakebite: Call for urgent global action to end death & suffering

HAI, KEI & STOPAIDS Statement on the WHO Consultative Expert Working Group on R&D

Measuring Medicine Prices, Availability, Affordability and Price Components (2nd Ed.)

Civil Society Urges Member States to Support the Dutch EU Presidency’s Vision on Access to Affordable Medicines

Trade Secrets Directive Will Threaten Access to Medicines Safety and Efficacy Data

Insulin Trade Profile

ACCISS Study Reveals Numerous Barriers Hindering Access to Insulin for Millions in Need

HAI Intervention on Ensuring Access to Antimicrobial Drugs, Diagnostics and Vaccines

Assessing EU Funding for R&D for Poverty-related and Neglected Diseases

HAI Intervention at the United Nations High-Level Panel on Access to Medicines

Access to High-priced Medicines in Hospital Settings in Europe: A Study in Four European Countries

Study Finds Access to High-priced Medicines May Differ Across EU

Why You Should Be Concerned About TTIP and Access to Medicines

Listen: ACCISS Study Investigator, David Beran, Speaks to The Lancet D&E About Insulin Access

European CSOs Call for Rejection of EU Trade Secrets Directive

Civil Society Has No Confidence in Stalled Framework for Engagement with Non-state Actors Process

2015

PRIME Example of How EMA is Pushing for Accelerated Market Approvals

Trilogue Negotiations on Commission’s Proposal for Trade Secrets Directive

Medicines Transparency Alliance (MeTA) Evaluation

Global Snakebite Initiative Appoints Health Action International as Secretariat

Multi-sectoral NGO Coalition Calls on Parliament to Defend Safeguards for Consumers, Journalists, Whistleblowers, Public Authorities and Workers

“Adaptive Licensing” or “Adaptive Pathways”: Deregulation Under the Guise of Earlier Access

NVTG Congres richt zich op toegang tot geneesmiddelen

Empty Gestures – The EU’s Commitments to Safeguard Access to Medicines

HAI and MSF Report Shows European Commission’s Access to Medicines Commitments are ‘Empty Gestures’

EU medicines policy & access to medicines